Responses
Inflammatory bowel disease
Original article
Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.